Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-15

FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a fixed-dose combination generic tablet of abacavir and lamivudine via an original ANDA from Aurobindo Pharma Limited for HIV-1 infection in combin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)